Patent · US Active

CDK inhibitors

US10189849B2 · kind B2 · utility

9Cited by
11References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 12, 2018
Grant dateJan 29, 2019
Priority date—
Expiry dateMar 12, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of formulae I, II or III, and pharmaceutically acceptable salts thereof, are useful as CDK inhibitors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.